Disease |
Disease |
Method |
Sample |
Expression pattern |
Dysfunction type |
Description |
PMID |
Source |
dyskeratosis congenita |
N/A |
N/A |
N/A |
mutation |
Disruption of telomerase trafficking by WRAP53 mutation causes dyskeratosis congenita. |
21205863 |
LncRNADisease
|
cancer |
N/A |
N/A |
N/A |
N/A |
WRAP53 promotes cancer cell survival and is a potential target for cancer therapy. |
21368886 |
LncRNADisease
|
cancer |
N/A |
N/A |
N/A |
expression |
A natural antisense transcript of TP53, WRAP53, was strongly augmented by idarubicin and etoposide. |
21441950 |
LncRNADisease
|
hepatocelluar carcinoma |
qPCR etc. |
HCC tissue |
up-regulated |
expression |
We found that lncRNA-UCA1 and lncRNA-WRAP53 were significantly higher in sera of HCC than those with chronic HCV infection or healthy volunteers. Our data suggested that the increased expression of UCA1 and WRAP53 was associated with advanced clinical parameters in HCC. |
26551349 |
Lnc2Cancer
|
|